CELULLAR DRUGS TRANSPORTERS. THE JOURNEY OF THE ORAL ANTIDIABETICS AGENTS TROUGH THE ORGANISM

Type 2 diabetes mellitus requires multiple pharmacological treatment in order to achieve therapeutic goals and control comorbidities. Therefore, treatment leads to drug interaction. It means that the observed effects, whether therapeutic or adverse, are the result of the concomitant administration o...

Full description

Bibliographic Details
Main Authors: Héctor Alejandro Serra, Cristian Suárez Cordo, Jorge Alvariñas, Julio César Bragagnolo, Gustavo Daniel Frechtel, Pilar Cean, Claudia Folino, Analía Dagum, Susana Salzberg
Format: Article
Language:Spanish
Published: Sello Editorial Lugones 2018-03-01
Series:Revista de la Sociedad Argentina de Diabetes
Subjects:
Online Access:https://www.revistasad.com/index.php/diabetes/article/view/40